Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia
Komabayashi T, Yakata A, Izawa T, Suda K, Noguchi M, Tsuboi M
doi:10.1016/j.ijheh.2021.113782
Phase 1 Trial Initiation Expected 2Q26 -- -- Strong Quarter-End Cash Position of $603 Million -- SAN DIEGO, April 29, 2026 /PRNewswire/ -- Viking Therapeutics, Inc
If I ration my doses of this miracle drug carefully, Ive got maybe four months until the effects will wear off and I turn back into, well, a pumpkin
If present, discontinuation should be considered, following the ASA guidance: withholding on the day of surgery for daily formulations and 1 week prior for weekly ones